Impact of age on the safety and efficacy of bevacizumab (BEV)-containing therapy in patients (pts) with primary ovarian cancer (OC): Analyses from the OTILIA German non-interventional study on behalf of the North-Eastern German Society of Gynaecological Oncology (NOGGO) Ovarian Cancer Working Group. 7. Juni 2016 Mustea, A., Wimberger, P., Oskay-Oezcelik, G., Jungberg, P., Meinerz, W., Reichert, D., Janssen, J., Keller, M., Richter, R., Harde, J., Klawitter, S., Wegenaer, A., Mueller, M., Sehouli, J., 2016. Ann Oncol 27(suppl_6), 296–312, 867P. doi:10.1093/annonc/mdw374.14 Abstract Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials-Analyses From the German Clinical RCC Registry. Marschner, N., Staehler, M., Müller, L., Nusch, A., Harde, J., Koska, M., Jänicke, M., Goebell, P.J., RCC Registry Group, 2016. Clin Genitourin Cancer. Clin Genitourin… Weiterlesen Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: Final results of the non-interventional study NABUCCO. Potthoff, K., Nusch, A., Söling, U., Hansen, R., Salat, Grebhardt, S., Marschner, N., 2016. Ann Oncol (2016) 27 (suppl_6): 236P. doi:10.1093/annonc/mdw365.15… Weiterlesen